Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global IVIG Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Injection
  • 1.3.3 Lyophilized Powder
• 1.4 Market Segment by Application
  • 1.4.1 Global IVIG Market Share by Application (2019-2025)
  • 1.4.2 Multiple Sclerosis (MS)
  • 1.4.3 Myasthenia Gravis (MG)
  • 1.4.4 Multifocal Motor Neuropathy (MMN)
  • 1.4.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
  • 1.4.6 Dermatomyositis
  • 1.4.7 Polymyositis
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global IVIG Market Size
  • 2.1.1 Global IVIG Revenue 2014-2025
  • 2.1.2 Global IVIG Sales 2014-2025
• 2.2 IVIG Growth Rate by Regions
  • 2.2.1 Global IVIG Sales by Regions 2014-2019
  • 2.2.2 Global IVIG Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 IVIG Sales by Manufacturers
  • 3.1.1 IVIG Sales by Manufacturers 2014-2019
  • 3.1.2 IVIG Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 IVIG Revenue by Manufacturers (2014-2019)
  • 3.2.2 IVIG Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global IVIG Market Concentration Ratio (CR5 and HHI)
• 3.3 IVIG Price by Manufacturers
• 3.4 Key Manufacturers IVIG Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into IVIG Market
• 3.6 Key Manufacturers IVIG Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Injection Sales and Revenue (2014-2019)
  • 4.1.2 Lyophilized Powder Sales and Revenue (2014-2019)
• 4.2 Global IVIG Sales Market Share by Type
• 4.3 Global IVIG Revenue Market Share by Type
• 4.4 IVIG Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global IVIG Sales by Application

6 United States

• 6.1 United States IVIG Breakdown Data by Company
• 6.2 United States IVIG Breakdown Data by Type
• 6.3 United States IVIG Breakdown Data by Application

7 European Union

• 7.1 European Union IVIG Breakdown Data by Company
• 7.2 European Union IVIG Breakdown Data by Type
• 7.3 European Union IVIG Breakdown Data by Application

8 China

• 8.1 China IVIG Breakdown Data by Company
• 8.2 China IVIG Breakdown Data by Type
• 8.3 China IVIG Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World IVIG Breakdown Data by Company
• 9.2 Rest of World IVIG Breakdown Data by Type
• 9.3 Rest of World IVIG Breakdown Data by Application
• 9.4 Rest of World IVIG Breakdown Data by Countries
  • 9.4.1 Rest of World IVIG Sales by Countries
  • 9.4.2 Rest of World IVIG Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Green Cross
  • 10.1.1 Green Cross Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of IVIG
  • 10.1.4 IVIG Product Introduction
  • 10.1.5 Green Cross Recent Development
• 10.2 BSV
  • 10.2.1 BSV Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of IVIG
  • 10.2.4 IVIG Product Introduction
  • 10.2.5 BSV Recent Development
• 10.3 Hualan Bio
  • 10.3.1 Hualan Bio Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of IVIG
  • 10.3.4 IVIG Product Introduction
  • 10.3.5 Hualan Bio Recent Development
• 10.4 RAAS
  • 10.4.1 RAAS Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of IVIG
  • 10.4.4 IVIG Product Introduction
  • 10.4.5 RAAS Recent Development
• 10.5 YUAN DA SHUYANG
  • 10.5.1 YUAN DA SHUYANG Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of IVIG
  • 10.5.4 IVIG Product Introduction
  • 10.5.5 YUAN DA SHUYANG Recent Development
• 10.6 Kangbao Bio
  • 10.6.1 Kangbao Bio Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of IVIG
  • 10.6.4 IVIG Product Introduction
  • 10.6.5 Kangbao Bio Recent Development
• 10.7 Tiantan Bio
  • 10.7.1 Tiantan Bio Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of IVIG
  • 10.7.4 IVIG Product Introduction
  • 10.7.5 Tiantan Bio Recent Development
• 10.8 Taibang Bio
  • 10.8.1 Taibang Bio Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of IVIG
  • 10.8.4 IVIG Product Introduction
  • 10.8.5 Taibang Bio Recent Development
• 10.9 Weiguang Bio
  • 10.9.1 Weiguang Bio Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of IVIG
  • 10.9.4 IVIG Product Introduction
  • 10.9.5 Weiguang Bio Recent Development
• 10.10 SIBP
  • 10.10.1 SIBP Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of IVIG
  • 10.10.4 IVIG Product Introduction
  • 10.10.5 SIBP Recent Development
• 10.11 TONROL
• 10.12 RUIDE Bio
• 10.13 BOYA Bio
• 10.14 RUIDE Bio
• 10.15 Xinxing Medicine
• 10.16 Weilun Bio
• 10.17 WIBP

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 IVIG Sales Channels
  • 11.2.2 IVIG Distributors
• 11.3 IVIG Customers

12 Market Forecast

• 12.1 Global IVIG Sales and Revenue Forecast 2019-2025
• 12.2 Global IVIG Sales Forecast by Type
• 12.3 Global IVIG Sales Forecast by Application
• 12.4 IVIG Forecast by Regions
  • 12.4.1 Global IVIG Sales Forecast by Regions 2019-2025
  • 12.4.2 Global IVIG Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of IVIG is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for IVIG.

This report studies the global market size of IVIG, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the IVIG sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP

Market Segment by Product Type
Injection
Lyophilized Powder

Market Segment by Application
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the IVIG status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key IVIG manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of IVIG are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025